Clinical Trials in Cosenza, Cosenza
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Marginal Zone Lymphoma (MZL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna59 enrolled15 locationsNCT06823960
Recruiting
Italian Anderson Fabry Disease Cardiovascular Registry
Fabry Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna800 enrolled54 locationsNCT06806813